myHIVteam

Egrifta SV (Tesamorelin) is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to reduce excess abdominal fat in adult patients living with HIV and lipodystrophy. Here are some key points about Egrifta:

- How it works: Egrifta is a growth hormone-releasing factor (GHRF) analog that helps metabolize Show Full Answer

Egrifta SV (Tesamorelin) is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to reduce excess abdominal fat in adult patients living with HIV and lipodystrophy. Here are some key points about Egrifta:

- How it works: Egrifta is a growth hormone-releasing factor (GHRF) analog that helps metabolize hard belly fat.
- Administration: It is generally injected subcutaneously once a day.
- Side effects: Common side effects include redness and itchiness at the injection site, swelling in the hands and feet, and muscle and joint pain. Rare but serious side effects include an increased risk of certain cancers, diabetes, and allergic reactions.

For more details and to connect with others who have tried Egrifta, you can visit the myHIVteam website.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

HIV and Hard Belly: Lipodystrophy Pictures, Symptoms, and Treatment | myHIVteam

Egrifta (Tesamorelin) for HIV | myHIVteam